LONDON (AP) — Britain's leader sought to deflect criticism that he's been working too closely with U.S. drugmaker Pfizer in its proposed $106-billion takeover of the Anglo-Swedish firm AstraZeneca.
Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Sun, 05/11/2014 - 4:32am
LONDON (AP) — Britain's leader sought to deflect criticism that he's been working too closely with U.S. drugmaker Pfizer in its proposed $106-billion takeover of the Anglo-Swedish firm AstraZeneca.